High tigecycline resistance in multidrug-resistant Acinetobacter baumannii
Author(s) -
Shiri NavonVenezia,
Azita Leavitt,
Yehuda Carmeli
Publication year - 2007
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkm018
Subject(s) - tigecycline , acinetobacter baumannii , etest , microbiology and biotechnology , multiple drug resistance , biology , antibiotics , medicine , bacteria , pseudomonas aeruginosa , genetics
Multidrug-resistant (MDR) Acinetobacter baumannii is increasing in our hospital and worldwide, raising the necessity of finding effective therapies. We aimed to evaluate the in vitro activity of tigecycline against MDR A. baumannii clones isolated before tigecycline was used in our institution.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom